Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Baolan LI"'
Autor:
Cong Zhao, Li Tong, Bin Liu, Fei Qi, Zhiyun Zhang, Yi Guo, Yanxia Liu, Ying Wang, Lina Zhang, Baohua Lu, Baolan Li, Tongmei Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatocyte growth factor (HGF) is a peptide-containing multifunctional cytokine, which is overexpressed and/or activated in multiple malignancies and is reported to be associated with tumor development and inferior survival. At pr
Externí odkaz:
https://doaj.org/article/f270c847156348d9b5bf9ed95e9493e3
Autor:
Ying Wang, Yanxia Liu, Zhiyun Zhang, Baohua Lu, Yuan Gao, Li Tong, Mingming Hu, Peter Ping Lin, Baolan Li, Tongmei Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Purpose This study aimed to investigate the clinical utility of diverse aneuploid circulating tumor cell (CTC) subtypes and particularly CTC-associated white blood cell (CTC-WBC) clusters in predicting treatment response, prognosis and real-
Externí odkaz:
https://doaj.org/article/b1e4cf2078b74e04bf4f05333974cccb
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Purpose For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efficacy and prognosis those two
Externí odkaz:
https://doaj.org/article/578ef8698f604edca4da4c0990140976
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 17 (2023)
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have limited or no response in some certain patients of non-small-cell lung cancer (NSCLC). However, real-world survival analyses comparing clinical data and EGFR-pla
Externí odkaz:
https://doaj.org/article/894937961e234022be548af3d9dc93b1
Autor:
Tongmei Zhang, Lina Zhang, Yuan Gao, Ying Wang, Yanxia Liu, Hongmei Zhang, Qunhui Wang, Fanbin Hu, Jie Li, Jinjing Tan, Daisy Dandan Wang, Olivier Gires, Peter Ping Lin, Baolan Li
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2891-2909 (2021)
Prognosticating the efficacy of anti‐angiogenic therapy through longitudinal monitoring and early detection of treatment resistance in cancer patients remain highly challenging. In this study, co‐detection and comprehensive phenotypic and karyoty
Externí odkaz:
https://doaj.org/article/25e5cf5fcef84a67b539d56385114b3d
Autor:
Jianhua Shi, Guimin Chen, Haitao Wang, Xiuxiu Wang, Baohui Han, Kai Li, Qiming Wang, Li Zhang, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhian Liu
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2345-2351 (2021)
Abstract Background There is a lack of targeted therapeutic options for squamous cell lung cancer (SCC). Accelerated hypertension is an issue with many targeted therapies for lung cancer. This study aimed to analyze the efficacy of anlotinib, based o
Externí odkaz:
https://doaj.org/article/e503822267b54182b44be20d575273a6
Autor:
Ying WANG, Yi GUO, Haifeng LIN, Lina ZHANG, Hongmei ZHANG, Qunhui WANG, Fanbin HU, Jie LI, Baolan LI, Tongmei ZHANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 8, Pp 583-590 (2021)
Background and objective Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid growth, early metastasis and acquired therapeutic resistance, and the prognosis is extremely poor. Studies have proved that the stem cell
Externí odkaz:
https://doaj.org/article/9eaf84208d634deaa13266ec79f7a12b
Autor:
Tongmei ZHANG, Baolan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 3, Pp 188-195 (2021)
With the development of precise medicine, targeted therapy has greatly improved the survival and prognosis of patients in advanced non-small cell lung cancer (NSCLC) with oncogenic drivers. However, no matter which kinds of targeted therapy are inevi
Externí odkaz:
https://doaj.org/article/28d59603b612468eaf849519edb813da
Autor:
Mingming Hu, Jinjing Tan, Zhentian Liu, Lifeng Li, Hongmei Zhang, Dan Zhao, Baolan Li, Xuan Gao, Nanying Che, Tongmei Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundYoung lung cancer as a small subgroup of lung cancer has not been fully studied. Most of the previous studies focused on the clinicopathological features, but studies of molecular characteristics are still few and limited. Here, we explore
Externí odkaz:
https://doaj.org/article/fe922c959fc540b88822eb365290a75c
Autor:
Cong Zhao, Zhiyun Zhang, Xingsheng Hu, Lina Zhang, Yanxia Liu, Ying Wang, Yi Guo, Tongmei Zhang, Weiying Li, Baolan Li
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
BackgroundHyaluronan (HA) is one of the essential elements of the extracellular matrix (ECM), involved in the onset of metastasis in various tumors. The interaction and binding of the ligand–receptor HA/cluster of differentiation-44 (CD44) regulate
Externí odkaz:
https://doaj.org/article/612ca8e4a924450cbb490aa88e4932ee